Bulletin
Investor Alert

New York Markets Close in:

The Wall Street Journal Archives | Email alerts

June 29, 2020, 8:28 p.m. EDT

Las Vegas workers sue, saying casinos failed to protect them from coronavirus

One of first lawsuits seeking to hold employers liable

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Caesars Entertainment Inc. (CZR)
  • X
    MGM Resorts International (MGM)

or Cancel Already have a watchlist? Log In

By Katherine Sayre


Bloomberg News
Tourists view the water fountains at the MGM Resorts International Bellagio Resort & Casino in Las Vegas in 2018.

Las Vegas Strip hospitality workers filed a lawsuit against casino operators on Monday, accusing the companies of failing to protect employees from COVID-19, one of the first efforts to hold employers legally responsible for infections as cases in the U.S. surge.

The lawsuit, filed in U.S. District Court in Las Vegas against the owners of Harrah’s, MGM Grand and Bellagio casinos, says the companies didn’t immediately shut down food-and-beverage outlets and other areas after learning of positive cases, didn’t immediately inform employees when co-workers tested positive and didn’t adequately contact-trace before allowing colleagues of infected employees to return to the job.

Culinary Union Local 226 and Bartenders Union Local 165, through their joint bargaining agency, filed the lawsuit against Harrah’s Las Vegas LLC, a subsidiary of Caesars Entertainment Corp. /zigman2/quotes/205281174/composite CZR -1.62%  , and the Signature Condominiums LLC at the MGM Grand and Bellagio LLC, subsidiaries of MGM Resorts International /zigman2/quotes/209932643/composite MGM -0.95%  . The lawsuit said unsafe working conditions violate the unions’ contract. The unions represent 60,000 hospitality workers.

In response to the lawsuit, MGM Resorts said the company has offered free testing to workers before returning to the job and requires testing for anyone with symptoms or who might have been exposed. Managers have been trained in response protocols and work closely with public-health officials on contract tracing following positive test results, according to the company.

An expanded version of this report appears on WSJ.com:

Also popular on WSJ.com:

COVID-19 drug remdesivir to cost $3,120 for typical patient.

How to get a big break on the cost of college: Just ask.

/zigman2/quotes/205281174/composite
US : U.S.: Nasdaq
$ 37.65
-0.62 -1.62%
Volume: 5.54M
Aug. 11, 2020 3:53p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.16 billion
Rev. per Employee
$109,947
loading...
/zigman2/quotes/209932643/composite
US : U.S.: NYSE
$ 21.45
-0.20 -0.95%
Volume: 30.94M
Aug. 11, 2020 3:53p
P/E Ratio
5.69
Dividend Yield
0.05%
Market Cap
$10.68 billion
Rev. per Employee
$213,874
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.